[1] |
JIANG Yuanyuan, WEI Wenfei, WU Jingya, LI Huawen.
Application of organoids in drug screening of gynecological malignant tumors
[J]. China Oncology, 2024, 34(11): 1053-1060.
|
[2] |
ZHOU Changming, WANG Zezhou, ZHENG Ying.
Interpretation of US cancer statistics 2023 and its implications for cancer prevention and treatment in China
[J]. China Oncology, 2023, 33(2): 117-125.
|
[3] |
PANG Yi, WU Chunxiao, GU Kai, BAO Pingping, WANG Chunfang, SHI Liang, GONG Yangming, XIANG Yongmei, DOU Jianming, WU Mengyin, FU Chen, SHI Yan.
Analysis of current status of cervical cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2022, 32(6): 519-526.
|
[4] |
WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan.
Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016
[J]. China Oncology, 2022, 32(2): 97-105.
|
[5] |
ZHANG Jian , SHEN Weina , JI Dongmei , WANG Leiping , GONG Chengcheng , HU Xichun .
FUSCC criteria for the management of targeted drug-induced interstitial lung disease in solid tumors
[J]. China Oncology, 2021, 31(4): 241-249.
|
[6] |
LU Ming, HONG Yuming, ZHENG Chaohui, CHEN Xiaofang, LIANG Zhenyuan.
Factors influencing postoperative hypercoagulability of free flap reconstruction for head and neck tumor
[J]. China Oncology, 2021, 31(4): 317-322.
|
[7] |
WU Chunxiao , GU Kai , PANG Yi , BAO Pingping , WANG Chunfang , SHI Liang , GONG Yangming , XIANG Yongmei , DOU Jianming , SHI Yan , FU Chen .
Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016
[J]. China Oncology, 2021, 31(10): 879-891.
|
[8] |
WU Chunxiao , GU Kai , GONG Yangming , ZHENG Rongshou , WANG Shaoming , CHEN Ru , ZHANG Siwei , SHI Yan , WEI Wenqiang , FU Chen , HE Jie .
Analysis of incidence and mortality of colorectal cancer in China, 2015
[J]. China Oncology, 2020, 30(4): 241-245.
|
[9] |
XIAO Jialong, ZHENG Ying.
The global prevalence and prevention progress of lung cancer
[J]. China Oncology, 2020, 30(10): 721-725.
|
[10] |
KANG Xun,ZHANG Xiyou,CHEN Feng,LI Dandan,DONG Qianqian,SONG Qingkun,ZHONG Xiaosong,LI Wenbin .
The toxicity of chimeric antigen receptor T-cell immunotherapy in B-cell lymphoma: a Meta-analysis
[J]. China Oncology, 2019, 29(8): 568-575.
|
[11] |
BAO Pingping, WU Chunxiao, ZHANG Minlu, PENG Peng, WANG Chunfang, GONG Yangming, GU Kai, XIANG Yongmei, SHI Liang, PANG Yi, SHI Yan, FU Chen.
Report of cancer epidemiology in Shanghai, 2015
[J]. China Oncology, 2019, 29(2): 81-99.
|
[12] |
WANG Jue, DU Yan, WANG Yejing, et al.
Incidence and mortality of ovarian cancer among permanent residents in the Former Luwan District of Shanghai between 2002 and 2011
[J]. China Oncology, 2018, 28(6): 407-410.
|
[13] |
LIU Xiaoxue, YU Chuanhua, ZHOU Wei, et al.
Trends in colorectal cancer mortality for the last 30 years in China
[J]. China Oncology, 2018, 28(3): 177-183.
|
[14] |
ZHOU Wei, ZHANG Zhijiang, WANG Lijun, et al.
Joinpoint regression analysis for the trends of cervical cancer mortality between 1987-2014 in China
[J]. China Oncology, 2017, 27(8): 634-640.
|
[15] |
WU Chunxiao, BAO Pingping, HUANG Zhezhou, et al.
The patterns of head and neck cancer incidence in Shanghai from 2003 to 2012
[J]. China Oncology, 2017, 27(6): 406-414.
|